Glimisave Mv 2.3mg Tablet belongs to the therapeutic classification of Antidiabetic Agents. The primary composition for this medicine is Glimepiride 2 MG, Metformin 500 MG, Voglibose 0.3 MG.

Some diabetic patients taking Glimisave MV 2.3 Tablet 10's may develop a rare but serious condition called lactic acidosis. In this condition, there is too much lactic acid accumulated in the blood. So, your liver and kidney proper functioning is required for the elimination of excess lactic acid from the blood. You should not take Glimisave MV 2.3 Tablet 10's if you have kidney disease, as measured by a blood test. Glimisave MV 2.3 Tablet 10's may lower vitamin B12 levels, so try to have blood test annual blood and vitamin. Glimisave MV 2.3 Tablet 10's when used with or without insulin has the tendency to extremely lower the blood sugar level. So, the doctor may lower the dose of insulin. Glimisave MV 2.3 Tablet 10's may lower your thyroid stimulating hormone (TSH), so an annual check up of TSH is suggested.